THE FAILURE OF MASSIVE SALICYLATE THERAPY TO SUPPRESS THE INFLAMMATORY REACTION IN RHEUMATIC FEVER

Autor: Harris Tn

Publikováno v: The American Journal of the Medical Sciences. 213:482-487

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e059c50729944f36b05807fc7f88629d
https://doi.org/10.1097/00000441-194704000-00014

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety and Efficacy of Prophylactic Amiodarone After Left Ventricular Assist Device.

Autor: Graboyes SDT; From the Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, North Carolina.; Department of Pharmacy, University of California, Davis Medical Center, Sacramento, California., Kline TM; From the Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, North Carolina., Harris TN; Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina., Iyer PS; From the Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, North Carolina., Hollis IB; From the Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, North Carolina.

Publikováno v: ASAIO journal (American Society for Artificial Internal Organs : 1992) [ASAIO J] 2023 Jan 01; Vol. 69 (1), pp. 96-100. Date of Electronic Publication: 2022 Feb 01.

Overcoming anti-PEG antibody mediated accelerated blood clearance of PEGylated liposomes by pre-infusion with high molecular weight free PEG.

Autor: McSweeney MD; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: morgan_mcsweeney@unc.edu., Price LSL; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA., Wessler T; Department of Mathematics, University of North Carolina, Chapel Hill, NC, USA., Ciociola EC; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: liz_ciociola@med.unc.edu., Herity LB; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: herity@email.unc.edu., Piscitelli JA; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: joseph_piscitelli@unc.edu., DeWalle AC; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: adewalle@live.unc.edu., Harris TN; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: taylornh@email.unc.edu., Chan AKP; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: kwan.chan.13@alumni.ucl.ac.uk., Saw RS; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: ran.saw.14@alumni.ucl.ac.uk., Hu P; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA. Electronic address: peiqi_hu@med.unc.edu., Jennette JC; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA. Electronic address: charles_jennette@med.unc.edu., Forest MG; Department of Mathematics, University of North Carolina, Chapel Hill, NC, USA. Electronic address: forest@unc.edu., Cao Y; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: yanguang@unc.edu., Montgomery SA; Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC, USA; Lineburger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA. Electronic address: stephanie_montgomery@med.unc.edu., Zamboni WC; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA. Electronic address: zamboni@email.unc.edu., Lai SK; Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, USA; UNC/NCSU Joint Department of Biomedical Engineering, University of North Carolina, Chapel Hill, NC, USA; Department of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill, NC, USA. Electronic address: lai@unc.edu.

Publikováno v: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2019 Oct; Vol. 311-312, pp. 138-146. Date of Electronic Publication: 2019 Aug 24.

A preparation of Fc fragment of normal mouse IgG1 for production of rabbit anti mouse IgG1 serum.

Autor: Harris TN, Harris S, Henri EM

Publikováno v: Journal of immunological methods [J Immunol Methods] 1975 Sep; Vol. 8 (3), pp. 203-12.